Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Federica FulgheriDepartment of Life and Environmental Sciences, University of Cagliari, 09042 Monserrato, Italy.ORCID 0000-0002-7858-1605
Fabrizio AngiusDepartment of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, 09042 Cagliari, Italy.ORCID 0000-0001-6613-603X
Matteo PerraDepartment of Life and Environmental Sciences, University of Cagliari, 09042 Monserrato, Italy.ORCID 0000-0002-9906-990X
Ilenia DeloguDepartment of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, 09042 Cagliari, Italy.ORCID 0000-0002-8846-5683
Silvia PuxedduDepartment of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, 09042 Cagliari, Italy.ORCID 0009-0008-4612-9316
Milen I GeorgievLaboratory of Metabolomics, Department of Biotechnology, Institute of Microbiology, Bulgarian Academy of Sciences, 4002 Plovdiv, Bulgaria.ORCID 0000-0001-5248-6135
Renáta NovotnáDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic.ORCID 0000-0001-7877-555X
Jana FrankováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic.ORCID 0000-0002-9344-3569
Misia LobinaDepartment of Life and Environmental Sciences, University of Cagliari, 09042 Monserrato, Italy.
Aldo ManzinDepartment of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, 09042 Cagliari, Italy.ORCID 0000-0003-2961-3428
Maria ManconiDepartment of Life and Environmental Sciences, University of Cagliari, 09042 Monserrato, Italy.ORCID 0000-0003-4818-2344
Maria Letizia MancaDepartment of Life and Environmental Sciences, University of Cagliari, 09042 Monserrato, Italy.ORCID 0000-0002-3787-257X
Funding
Next Generation EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases PE00000007, INF-ACTPalacký University Olomouc 61989592Programme Research Innovation and Digitalisation for Smart Transformation BG16RFPR002-1.014-0003-C01
6 · The paper itself
Abstract
Herpes simplex virus type 1 (HSV-1) is a widespread pathogen responsible for recurrent infections, primarily affecting the skin and mucous membranes. With the aim of targeting both the viral infection and the associated inflammatory response, biotechnologically produced
Indexed as
antioxidantantiviral activitycutaneous deliverydrug delivery systemnanocarriersNormal Human Dermal FibroblastsVero cells
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Liposomal Delivery of a Biotechnological · full record | OpenQuestion